Healthcare - Biotechnology - NASDAQ - US
$ 0.96
-7.69 %
$ 8.87 M
Market Cap
0.2
P/E
Price Target
Average
--100.00%
Revenue Forecast
Estimate
63.83%
EBIT
Estimate
12.59%
Net Income
Estimate
87.09%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Jaguar Health, Inc.
JAGX has no price targets from Wall Street.
REVENUE FORECAST
Revenue Forecast Chart JAGX
EBIT FORECAST
EBIT Forecast Chart JAGX
NET INCOME FORECAST
Net Income Chart JAGX